## 



## 

|ontents|ontents|||||||
|---|---|---|---|---|---|---|---|
|Reference and administrative|||information||||1 —2|
|Statement<br>from the CEO|||||||3 —4|
|Statement<br>from the Chair|ofTrustees|||||||
|Governance|||||||6 —7|
|Background<br>and Strategy|||||||8 —10|
|Strategic report —Objectives||&activities||||||
|Mountbatten<br>pyramid|||||||12 —13|
|Key Achievements<br>and Performance|||||||14|
|Services across Mountbatten|||isle of Wight||and Mountbatten|Hampshire|15 —24|
|Quality|||||||25 —35|
|Education<br>and Training|||||||36 —37|
|Mandatory<br>training|||||||38|
|Research|||||||39|
|Income generation|||||||40 —41|
|Communications|||||||42 —44|
|Estates and Facilities|||||||45 —47|
|Catenng|||||||48|
|People Services|||||||49 —54|
|Information<br>Technology|||||||55 —57|
|Trustees'<br>duty to promote|the success of||||the Charity —Section 172statement||58 —60|
|Sustainabihty<br>and carbon|reporting||||||61|
|Finanaal<br>review|||||||62|
|Public benefit statement|||||||63|
|Statement<br>oftrustees'<br>responsibilities|||||||64|
|Independent<br>auditor's<br>report|||||||65 —67|
|Consolidated<br>statement<br>of financial||||activities|||68|
|(incorporating<br>an income|and||expenditure||account)|||
|Balance sheet|||||||69|
|Consolidated<br>statement<br>ofcash flows|||||||70|
|Notes to the financial<br>statements|||||||71 —97|





## 



|Bankers:||NatWest|||||
|---|---|---|---|---|---|---|
|||NatWest<br>House|||||
|||Riverway|||||
|||Newport|||||
|||Isle of Wight|||||
|||PO30 SUX|||||
|Investment|Managers:|Brewin Dolphin|||(Retired March 2023)||
|||Vantage Point|||||
|||Woodwater||Park|||
|||Pynes<br>Hill|||||
|||Exeter|||||
|||EX2 SFD|||||
|Investment|Managers:|CCLA Fund||Managers||Ltd|
|||)appointed||April|2023)||
|||BSQueen|Victona Street||||
|||London|||||
|||EC4V 4ET|||||
|Investment|Managers:|Ruffer<br>LLP|(appointed|||Apnl 2023)|
|||80Victona||Street|||
|||London|||||
|||SW1E SIL|||||
|Solicitors:||Bates Wells||LLP|||
|||10Queen|Street||Place||
|||London|||||
|||EC4R 1BE|||||
|Solicitors:||Glanwlles|LLP||||
|||St Cross Business Park|||||
|||Newport|||||
|||Isle of Wight|||||
|||PO30 SBF|||||
|Auditor:||Atets Audit||Services Limited|||
|||Ashcombe||Court|||
|||Woolsack|Way||||
|||Godalming|||||
|||Surrey|||||
|||GU7 1LQ|||||





## 


## 

## 



## 

## 



## 



## 

## 

## 

## 

## 

## 



## 

## 




## 

|2.|We will meet the needs ofeveryone<br>who requires our care and support,|We will meet the needs ofeveryone<br>who requires our care and support,|ensuring<br>that no-one<br>is|ensuring<br>that no-one<br>is|ensuring<br>that no-one<br>is|ignored:|ignored:|
|---|---|---|---|---|---|---|---|
|~|Further<br>development<br>of a Children<br>and Young Adults<br>Service in partnership|with||Kissy Puppy (Isle of||Wight)|and|
||Naomi House and Jack's Place (Hampshire)|||||||
|~|A continuation<br>and further<br>development<br>of dementia<br>services and services|for|older, frail people|||||
|~|Advance Care Planning<br>—continuing<br>to identify people with long term conditions<br>including<br>older people with|||||||
||frailty|||||||
|~|Health and Social Care Education|||||||
|~|Rapid Palliative<br>Care Discharge Faohtator at Unwersity<br>Hospital Southampton<br>to match the successful|||||model|on|
||the Isle of Wight|||||||
|~|Mountbatten<br>Coordmation<br>Centres —24/7 telephone<br>and visiting service across all|||our communities||||
|~|End of Life Domiciliary<br>Care provision<br>(Continuing<br>Health Care packages)|||||||
|~|New chanty shop model<br>Has been designed to integrate<br>Retail, I-lospitality|and|Clinical Services|||||
|3.|We will make sure that everything<br>Mountbatten<br>offers is sustainable|for|the|benefit offuture generations:||||
|~|A robust reserves<br>policy and Risk Register|||||||
|~|A Estates task and finish group ensures that our estate is 'fit for purpose'<br>for future|||generations.<br>Two|Capital|||
||Appeals are now planned<br>for the commg year, one for each site|||||||
|~|A bespoke 'sustainability'<br>strategic implementation<br>plan focusing on fundraising||and financial resilience|||||
|~|A detailed<br>'COVID-19' Action and Recovery<br>Plan which has now been fully integrated<br>into our strategic|||||plans||
|~|A new workforce<br>development<br>plan<br>is in process|||||||
|~|Development<br>of our ongoing education<br>programmes<br>both for our partners|and|our|local communities||||
|~|A new shops strategy<br>and a growth<br>plan for our Hampshire<br>shops headed<br>up|by|the|new Head of Retail|Business|||
||Development<br>and supported<br>by the Retail/shops<br>Advisory<br>Group|||||||
|In|order to further<br>support<br>our strategic<br>aims<br>we continue<br>to work<br>m partnership|||for the benefit|of our||local|
|communities<br>with examples<br>as follows:||||||||
||Isle of Wight<br>NHS Trust Community<br>Paediatric Team|||||||
||Kissy Puppy Chanty<br>(The Sophie Rolf Trust) —with a unique<br>Advisory<br>Group|||made up of key stakeholders||||
||Isle ofWight<br>Local Authority|||||||





## 

## 



## 

## 

## 

## 

## 



## 



## 

## 

## 

## 



## 

## 



## 



## 

## 



## 

## 

## 



## 

## 



## 

## 

## 

## 

## 

## 



## 



## 

## 

|Priority 1: Safety|Priority 1: Safety||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|Target||||||How we measure success|||||
|1.1The implementation||||of||All necessary drug formulanes|are built<br>in SystmOne,|the|||
|electronic|prescnbing||on|the||electronic patient record|||||
|Inpatient|Unit at|Mountbatten|||Isle|All appropnate<br>employees<br>are|trained<br>in the use ofthe||||
|ofWight|Hospice|||||Electronic Prescribing<br>function|in SystmOne<br>—do we|need|||
|||||||to explain what this means&|||||
|||||||Other health professionals,<br>including<br>GP's and community|||||
|||||||nurses are notified ofthe move to electromc prescribing||||in|
|||||||SystmOne|||||
|||||||Electronic Prescnbing<br>module|in SystmOne goes live.||||
|12 Development||of|robust|||Pharmacist<br>is in post, has completed<br>an mduction,<br>and|||has||
|Pharmacy|provision||at|||clear objectives set.|||||
|Mountbatten<br>Hampshire||||Hospice||Retain and develop<br>links with|the Royal South Hants||||
|with the|introduction||of|a Band|Ba|Pharmacy<br>service, building<br>links to enable rotational||staff|||
|Speaahst|Pharmacist||role.|||exposure to the spemalism<br>of|palliative care Pharmacy||and||
|||||||provide cover in Band Ba Pharmacist's<br>absence.|||||
|||||||Develop and agree robust medicines<br>management<br>audit|||||
|||||||programme<br>working<br>in coniunction<br>with the Medicines|||||
|||||||Safety and Optimisation<br>team.|||||



## 

|Tar et|||||How we measure|success|||
|---|---|---|---|---|---|---|---|---|
|2.1The|implementation||of||Rehabilitation-led|beds are available<br>and robust|||
|rehabilitation-led||beds|on the||procedures<br>are in|place to inform and support||employees|
|Inpatient|Unit at|Mountbatten||Isle|in the provision of patient care||||
|ofWight|Hospice||||Awareness<br>training|is provided<br>so employees|understand||
||||||why rehabilitation-led<br>beds are appropriate||at|a particular|
||||||stage of patient care||||
||||||Training on the processes and procedures<br>is||provided to||
||||||medics and nurses||||
||||||Data dashboard<br>in|place to monitor progress|that is||
||||||reported<br>monthly|at the Quality<br>and Governance|||
||||||Committee||||
||||||Evaluate and share the outcomes of setting||up||
||||||rehabilitation-led|beds with other hospices|||





## 

|2.2 The implementation|2.2 The implementation|of Nurse-|Mountbatten<br>non-medical<br>prescribing|education|
|---|---|---|---|---|
|Led beds on|the Inpatient|Unit at|programme<br>is approved<br>by Health Education<br>England||
|Mountbatten|Hampshire|Hospice|There is a clinical supervision<br>structure|in place for|
||||Advanced<br>Nurse Prescribers<br>facilitated|by the Medical|
||||Team||
||||Nurse-led<br>beds expanded<br>from respite|patients to include|
||||patients<br>admitted<br>for iron-infusions<br>and step down beds||
||||An evaluation<br>ofthe nurse-led<br>bed prolect will be||
||||completed<br>and results<br>included<br>m the|Quahty<br>Report and|
||||presented<br>at Quality and Governance|Committee|



## 

|3:People's experience|3:People's experience|3:People's experience|3:People's experience||||
|---|---|---|---|---|---|---|
|Priority 3: People's Experience|||||||
|Target|||||How we measure success||
|3.1Purchase|additional|land on the|||Land required to extend the car park has been||
|Mountbatten|Isle of Wight||Hospice|site to|purchased||
|allow for the|reconfiguration||of car|parking|The Gables and Oak House buildings<br>have been||
|which<br>will create increased|||capacity||demolished<br>by an approved<br>contractor||
||||||Design and layout for the car park has been||
||||||approved<br>and shared<br>with staff, volunteers|and,|
||||||stakeholders||
||||||A robust tender process has been carried out||
||||||which meets the requirements<br>ofthe project||
||||||and the successful contactor appointed||
||||||Extended car park is in use and meets needs|of|
||||||the service users||
|3.2 Refurbishment<br>ofthe Hazel Centre to|||||Refurbishment<br>work<br>is completed,||
|include a new|Cafe and|commercial||Kitchen|commissioned,<br>and signed off, including||
|area|||||compliance<br>registration<br>of fire safety||
||||||Redecoration<br>ofthe Hazel Centre communal||
||||||areas and refurbishment<br>ofoutdoor areas ofthe||
||||||cafe including<br>the purchase of new furniture||
||||||Cafe opening<br>hours increased<br>in a staged||
||||||approach<br>aiming for opening<br>seven days a||
||||||week, including<br>Christmas<br>Day||
||||||Feedback from employees,<br>patients<br>and wsitors||
||||||regarding<br>their experiences<br>ofthe Cafe||
||||||gathered<br>and a report produced.||





## 

|3 3 Develop|3 3 Develop|a portfolio of|language||that|staff,|Programme<br>of workshops<br>is in place to discuss|
|---|---|---|---|---|---|---|---|
|volunteers||and our community<br>are|||||with employees<br>and volunteers<br>about the|
|comfortable||with using regarding||death,||dying|importance<br>of having<br>a common<br>language<br>about|
|and bereavement|||||||death and dying, which gives them confidence|
||||||||when speaking to their networks|
||||||||Mandatory<br>training<br>on the use of a common|
||||||||language<br>about death and dying<br>is in place for|
||||||||all employees<br>and volunteers|
||||||||Employees<br>and volunteers<br>are surveyed<br>to|
||||||||assess their understanding<br>ofthe common|
||||||||agreed language<br>and the results analysed to|
||||||||ensure that it is embedded<br>in the culture|
||||||||Plan is in place to communicate<br>our ethos for a|
||||||||common<br>language<br>about death and dying both|
||||||||internally<br>and to the wider health community|
|3.4 Ensure||Mountbatten's|reach is||wider|and|Develop links across all communities,<br>attending|
|equitable|in terms ofaccess to services and||||||meetings<br>and events where possible within the|
|suppolt|||||||communities<br>we support|
||||||||Strengthen<br>links with Homelessness<br>support|
||||||||services including<br>misuse of substance<br>services|
||||||||and support<br>their development<br>around end-of-|
||||||||life care and provision|
||||||||Build on development<br>ofsupport/information|
||||||||clinics within the Hazel Centre and widen the|
||||||||network|
||||||||Produce a Equality,<br>diversity<br>and inclusion<br>policy|
||||||||Provide teaching sessions for Mountbatten|
||||||||employees<br>related to the cultural<br>beliefs of all|
||||||||community<br>groups and what<br>is important<br>to|
||||||||them|
||||||||Develop a procedure to support<br>staff when|
||||||||caring for members ofany under-represented|
||||||||gl'oup|
||||||||Explore opportunities<br>to utilise the Hazel Centre|
||||||||for diverse means|





## 

## 

|Overall rating for this service|Overall rating for this service|oviiwilulhc||
|---|---|---|---|
|u ize wzrzx|wfrz|iN~|~|
|liui rierwe|vilvriive i|sow|~|
|1st Awfl..|zxzrz|ootu~wx||
|nizvwr»ze|errwnuw&|duu~lw|0|
|li I,"4 wzv iv|rri Ilxn|ixnnawiw|rz|





## 

## 

## 



## 

## 

## 



## 

## 



## 

## 

## 




## 




## 

## 

## 





## 

## 



## 



## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 




## 

## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 

## 



## 



## 

## 

## 

## 

## 

## 



## 

|||Mountbatten|Isle ofWight|Isle ofWight||
|---|---|---|---|---|---|
|Media/Sites|Vacancies|||Applications|Hits|
|NHS Jobs|47|||517|31,232|
|Indeed|40|||378|47,512|
|IOW jobs|17|||72|4,868|
|Other Platforms||||40|2,152|
|||Mountbatten||Hampshire||
|Media/Sites|Vacancies|||Applications|Hits|
|NHS Jobs|65|||350|52,175|
|Indeed|65|||522|75,390|
|Other Platforms|||||252|
|||Mountbatten||Group||
|Media/Sites|Vacancies|||Applications|Hits|
|NHS Jobs|112|||867|83,407|
|Indeed|105|||900|122,902|
|IOW Jobs|17|||72|4,868|
|Other Platforms||||41|2,404|








## 

## 




## 

## 

## 

## 



## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 



## 



|Our Workforce|||
|---|---|---|
|As an organization,<br>we|are only as strong as|We communicate<br>with our staff in many different<br>ways<br>We|
|the people we' re made|up of. We pride|run an ongoing series ofgeneral open meetings<br>to which<br>all|
|ourselves<br>on the ability|to recruit, develop,|staff are invited<br>and at which any member ofstaff my raise|
|support<br>and train he best people<br>in each area||any issue or concern that they may have.|
|of our work. In order to do this, we need to<br>listen to our employees<br>and understand<br>what<br>kinds ofsupport,<br>information<br>and<br>development<br>opportunities<br>they want to see<br>from us.||We also have a policy whereby<br>all staff are able to have<br>regular and frequent<br>one to one meetings<br>with their line<br>manager<br>to discuss matters that relate directly to their day to<br>day work or how their work is affecting their day to day life.|
|||We have a formal annual<br>process of appraisal<br>to formally|
|||record the performance,<br>development<br>progress<br>and ambitions|
|||and future plans for the employee<br>and the Chanty.|
|||Finally, we have a formal process of whistleblowing<br>and an|
|||identified<br>whistleblowing<br>'champion'<br>to faalitate<br>swift|
|||disclosure<br>and resolution<br>to employment,<br>and other, issues|
|||which<br>may be sensitive,<br>difficult or contentious<br>in nature.|
|Suppliers|||
|We work with a range|of suppliers<br>but given|While the nature of our activities means that our largest|
|our location and what|it is that we do, they are|expense is Human<br>Resources we still spend significant|
|mostly local suppliers.|They do range from|amounts<br>with external<br>supphers.<br>We are committed<br>to|
|small independents<br>to|members<br>of large and|treating<br>them fairly and ensure that as far as possible we pay|
|sometimes<br>international|corporate groups.|them promptly<br>and deal with them equitably.<br>We run two|
|We value our relationships<br>with<br>all of our||creditor payment<br>runs every month to ensure that we are able|
|suppliers<br>and try hard to build good||to pay suppliers<br>promptly<br>and within agreed credit terms.|
|relationships<br>with<br>all ofour suppliers.|||



## 

## 

## 



## 

## 

## 



## 

## 

## 



## 



## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 



||||rv <br>la0 <br>r4|o<br> 0|4l||||th<br>O<br>th<br>I<br>01<br>vt|m<br>lh<br>r<br>IU<br>0<br>PV|ID<br>ch<br>I/I<br>Ca<br>IU||'llo<br>IU<br>IDo<br>m<br>Ol||||IDD<br>Co<br>CO<br>IVo|rh<br>fa|m<br>m<br>Ol<br>r<br>ID<br>IO||00<br>14<br>ID<br>hl|o<br>fa<br>Itl<br>ca||IVo<br>fx<br>IU||IV<br>Ol<br>IU|||Ol<br>Ol<br>CO<br>VVfa|C<br>Cla0<br>V||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||||||||||||||||||||||||||Vl0||
|||||||||||||||||||||||||||||||tU||
|||||||||||||||||||||||||||||||Cl||
|||||'0|4/||||Ch|'|O||||||m|||||||||||||DN||
|||||IUJ<br>Vl<br>Ct|||||ID<br>IU<br>00O<br>Ca<br>m||Ol<br>'0<br>41<br>IV||||||Va<br>at|||||||||||at<br>fa<br>m<br>Ul<br>m|o<br>ID<br>m|C||
|||||||||||||||||||||||||||||||Ct||
|||||||||||||||||||||||||||||||E||
|||||'0<br>Cl<br>IJ<br>tU|4/||CI<br>m<br>m||o <br>IO<br>OI<br>co<br>at<br>co|m41<br>I<br>IU<br>va|Dl<br>af<br>ID<br>IU||oo<br>IO<br>ID<br>Ul<br>co||IVI<br>mm<br>IO<br>rh||m<br>CI<br>41|vl'm<br>ID<br>/V|oO<br>CO<br>ta||o<br>CI<br>IV|o<br>41<br>CO||o<br>Ca<br>Ia||Oo<br>a|||IO<br>ID<br>co<br>Mat|tU<br>00<br>ta<br>'Cl<br>CJ||
|||||||||||||||||||||||||||||||ta||
|||||||||||||||||||||||||||||||Cl||
|||||||||||||||||||||||||||||||0||
||||IVO <br>14|0|4/||m<br>IO<br>fa<br>ID<br>la||m<br>th<br>ht<br>m<br>ao|ao<br>rh <br>CQ<br>ar|r<br> o<br>ID<br>m'|Olo<br>r<br>Ch|O<br>Ol<br>rh<br>IO||m<br>/4<br>m<br>Ul<br>Ol||Ul<br>t4<br>r<br>Ol<br>UJ<br>CO|Co<br>O<br>CJ|CI<br>CI|||O<br>CI<br>CJ<br>I4||m41<br>CQ<br>00<br>rh||fflh<br>I<br>Co<br>Co<br>m||Ol<br>CQ<br>faIa|M<br>IO<br>Mo<br>I/I|Cl<br>D||
|||||||||||||||||||||||||||||||0||
|||||10 <br>CJ<br>IJ<br>4/|4l||o<br>o||ca<br>m<br>0<br>tfl<br>m|'|af<br>tx<br>Ch<br>rv||m<br>ca<br>Ol||||mo<br>af<br>ID||O<br>Ifl<br>\0|||||CI'||I<br>at||CI<br>m|at<br>M<br>m|0<br>C<br>to000||
|||||||||||||||||||||||||||||||Ct||
|||||||||||||||||||||||||||||||C||
||0<br>0VV<br>CI<br>4I<br>0<br>'00|||'0<br>Ct<br>IJ<br>Vl<br>41<br>C|W||ID<br>Ct<br>ra<br>Mm<br>IU||I/1<br>ra<br>at<br>m<br>ID <br>ca'|Ca<br>m<br>ca<br>al<br>m<br> H|00<br>ID<br>ar<br>/V<br>m'|r<br>Cho<br>r0|mo<br>I/I<br>ID||m<br>rri<br>th||m<br>m<br>O<br>co|oo|ato<br>IO<br>Ch<br>r||IO<br>ID<br>r<br>ra|ooo<br>faaf||ID<br>ID<br>Co||ID<br>10<br>r<br>ra<br>Co<br>rri|||oo|tlo04<br>CI<br>Qt<br>00L<br>QI||
||4I|||||||||||||||||||||||||||||||
||CLx|||||||||||||||||||||||||||||Ql||
||Cl<br>lo0|||||||||||||||||||||||||||||0<br>CI||
||ta||||Cl|||||||||||||||||||||||||||
||E04||||0||ra||ra|IVI|Cf|Ul||||||||||||||||||V<br>Cl||
||IO0<br>D<br>4C<br>N<br>Cl|||||||||||||||||||C0<br>N0<br>lo40<br>VI<br>4I<br>NN0|||O0<br>100<br>la|||||||4<br>ta<br>tUt0<br>C<br>C0IJ||
|||||||||||||||||||||Cl|||CI<br>4I|||||||E0||
|||||||||||||||||||||||||||||||'0||
|IJ0<br>CI<br>Mla<br>IL<br>fa<br>0<br>0 4<br>CI 0<br>0. E ~<br>0 o m<br>QD th D<br>D<br>O<br>O<br>O<br>4I<br>la<br>lo<br>C 0<br>41<br>000<br>juW||||||V0<br>V<br>00<br>CJ<br>8<br>0<br>Eoo<br>0<br>C<br>4I 9<br>ro<br>E0<br>C<br>4 0 C<br>CI U|||IU<br>taU <br>o <br>0|e<br>Io<br> U<br>C<br> 0<br>U|CJ<br>4<br>000<br>ro<br> 0|0<br>CI<br>E' S.<br>E<br>E DL<br>Cl<br>fo<br>0 4<br>I-<br>IU|||'0<br>C<br>C<br>0|IU<br>4<br>ra<br>CI<br>ro <br>C<br>ta<br> J: <br>U|CJ<br>loU<br>rc<br>CI<br>C<br> e<br>0<br> C|0<br>U <br>& <br>C0<br>E|CI0<br> D<br> 0<br>Cl<br>x<br>Cl<br> 0|4I<br>0<br>Cl<br>Cl<br>E0IJC<br>0<br>'0<br>0 <br>x <br>0 <br>IUZ|0<br> 0<br> E<br> v<br> .|C0<br>E <br>Cl<br>C <br>0<br>C<br>'ar<br>00<br>Nal<br>0<br>IU<br>Z|CI<br> 0<br>41<br> 0<br>C<br>Cl <br>~<br>D<br>4Itax<br>4I<br> Z|0<br>C|V<br>C<br>Ctat<br>Cl<br>Jo<br>Cl<br>taC<br>I-|0<br>0<br>O<br>CI<br>Z|N<br>'D <br>0<br>0|lo<br> 0<br>lat<br> 00<br>C<br>ra<br>0|0<br>Cl<br>CIIJ<br>D0<br>la<br>0I-|CI <br>Cl<br>CJ<br>0<br>al<br>0<br>fa <br>IU<br>0|c<br>CJ<br>E<br>fit<br>ta<br>C<br> 0<br>tU<br> 0Z|





## 

|||||The|Group|Earl Mountbatten|Hospice|
|---|---|---|---|---|---|---|---|
|||||2023|2022|2023|2022|
||||Note|||E|E|
|Fixed assets:||||||||
|Tangible assets|||12|11,693,046|11,718,873|11,217,448|11,282,700|
|Investments|||13|31,629|7,810,840|2|5,910,849|
|||||11,724,675|19,529,713|11,217,450|17,193,549|
|Current assets:||||||||
|Stocks||||9,598|2,229|||
|Debtors|||16|689,763|3,819,692|542,822|1,922,060|
|Cash at bank and in||hand||8,884,194|1,076,983|6,446,730|563,622|
|||||9,583,555|4,898,904|6,989,552|2,485,682|
|Liabilities:||||||||
|Creditors: amounts||falling due within one year|17|(2,296,596)|(1,529,446)|(938,949)|(596,973)|
|Net current assets||||7,286,959|3,369,458|6,050,603|1,888,709|
|Total net assets|||20|19,011,634|22,899,171|17,268,053|19,082,258|
|Funds:||||||||
|Restricted funds||||3,194,784|3,221,019|3,194,784|3,221,019|
|Restricted funds CMH||||220,950|239,486|||
|Unrestricted<br>funds:||||||||
|Designated<br>funds||||9,573,435|9,573.435|9,073,435|9,073,435|
|General funds||||6,022,465|9,865,231|4,999,834|6,787,804|
|Totalunrestricted|funds|||15,595,900|19,438,666|14,073,269|15,861,239|
|Total funds|||21|19,011,634|22,899,171|17,268,053|19,082,258|





## 

||||||Note||2023|||2022||
|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||E|||E|||
|Net cash|provided<br>by|(used in) operating||||||||||
|activities|||||22|||613,088|||(351,464)|
|Cash flows from investing|||activities:|||||||||
|Dividends|and interest|||||197,097|||138,425|||
|Purchase|of property,|plant and equipment||||(361,185)|||(535,835)|||
|Proceeds|from disposal|of property,||plant and||||||||
|equipment|||||||||26,833|||
|Proceeds|from sale of|investments||||7,190,429|||1,383,104|||
|Purchase|of investments|||||(1,257,072)|||(1,689,251)|||
|Movement<br>in portfolio||cash held for||investment||1,424,854|||(793,704)|||
|Net cash|used in investing||activities|||||7,194,123|||(1,470,428)|
|Change in cash and cash equivalents||||in the year||||7,807,211|||(1,821,892)|
|Cash and|cash equivalents||at the beginmng<br>ofthe|||||||||
|year||||||||1,076,983|||2,898,875|
|Cash and|cash equivalents||at the end ofthe year|||||8,884,194|||1,076,983|





## 

## 

## 

## 

## 



## 

## 

## 



## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 



|||||ra<br>raO <br>rc|ta<br> 0<br> I-|W||Irl<br>ID<br>QI<br>mra|Nl<br>PC<br>I||Dl<br>r<br>ID <br>0|UI<br>ID<br>m<br> O<br> M|m<br>ID<br>r|||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||||||||||||M|||||
|||||||||||||||ta|C|||
||||||||||||||||4I|||
|||||||||||||||Cl||||
||||||'0<br>00|W||r<br>Ca<br>UI<br>m'|00<br>Irt<br>Ct<br>m'||||I/I<br>CQ<br>ID|4I<br>4I<br>tU|Cl<br>V|||
||||||N<br>Ql|||mm|||||M|0|00|||
||||||CC|||||||||||||
|||||||||||||||Cl||||
|||||||||||||||U<br>ra <br>40|40<br> 0<br> V|||
|||||||||||||||4l|tU|||
|||||||||||||||0||||
||||||0|W|||M|||I/I||||||
||||||QI<br>V<br>tU|||ID<br>trl<br>O<br>Ql|DI<br>I<br>CQ<br>ID||Ql<br>r<br>ID|ID<br>m<br> O<br>m<br>ID|ID<br>CQ<br>CI|IJ<br>0|IU<br>0|||
||||||4||||||||m||10C|||
|||||||||||||||o||||
||||||||||||||||tU|||
|||||m <br>O <br>CC|0<br> 0|w||\0<br>m<br>Ql|00<br>O<br>Ca||cr<br>ca <br>ID<br>ra<br>f|rc<br>Dl<br>ra<br>tD<br>ra|m<br>ID<br>ra<br>ID|la|0<br>L<br>Ql<br>E<br>Ql|||
||||||||||||||Ct|0<br>CIo<br>Cl|Ia4I<br>E|||
||||||0<br>tU<br>IJ<br>Cl<br>CL|W||m<br>CQ<br>CII|rMcr<br>CQ||oo<br>CI<br>Ulla||o<br>o<br>m|CQ<br>rn<br>W<br>IU<br>IU<br>CI<br>rc|IU0<br>ta<br>Cl<br>0<br>IJ<br>fa|||
|||||||||||||||Ll|fa0||r|
|||||||||||||||0|Cl||Cl40|
||||||'0<br>V<br>N<br>CI<br>L|VJ||r<br>IQ<br>r<br>M <br>cQ|rD<br>CQ<br>aa<br> at<br>I||cr <br>00 <br>ID<br>ra<br>O<br>I/I|cc<br> la<br>Ql<br>cc<br>ID<br>rc|ID<br>cl'<br>rv<br>ra|CI<br>CI<br>CI<br>Ul<br>CI<br>Dl<br>IN00|Xl<br>Ul<br>C<br>0<br>IJ<br>Ia<br>IU||Itl<br>CL|
|||||||||||||||Z|0|||
|||||||||||||||0<br>CI<br>CI|0<br>0<br>Ql|||
|||||||||||||||CI|IJIJ|||
|||||||||||||||rc|ta|||
|||||||||||||||IU||||
|||||||||||||||Ul|IU<br>IU|||
|||||||||||||||10||||
||||N<br>Cl|||||||||||CI<br>E|0C<br>IU|||
||||IJ<br>fa||||||||||||ta|||
||||Oa0||||||||||||IU|||
||N||ZlC||||||||||||Cl|||
|IO <br>0|O<br>E<br>ECo<br>N<br>Nl<br>N C<br>la<br>IN<br>ta<br> —$ la<br>la||QI<br>C0<br>la<br>0<br>E0|||||U <br>0.<br>0Z<br>c <br>5|QtIJ<br>Cl.<br>0<br> Z<br>Ct<br>ta<br> Ja<br> 0||Cl <br>U <br>0. <br>0Z<br>C <br>O|ClV<br>Cl<br> 0<br> Z<br> C<br>Cl<br>ta<br> 0<br>C||J:<br>Cl<br>0<br>Cl<br>IU|Cl<br>Cl<br>Cl<br>Cl0<br>Yl|||
|QD .—Qa0<br>4I<br>C<br>la<br>Ia<br>0<br>N<br>4I<br>4I<br>0<br>0<br>Xzu.|||Cl<br>E0IJC||||CD|fa<br>Ja<br>0<br>0<br>ra <br>UJ|Qf<br> 0<br> u|V<br>Qt|fa<br>C<br>0<br>ra|Cl<br>tU<br>0<br>u||0<br>0<br>0<br>CI|IU <br>0<br>IU<br>S<br>'3|4:<br> Q<br>I/I<br>Cl<br>ta<br> u||





|||||/0<br>ruO <br>fu|0<br> 0|w||I/t<br>O'<br>ar<br>Q<br>Mm|Ol<br>O<br>«f<br>Ol||IO<br>trt<br>f|Ol<br>cr<br>fu<br>fu||Q<br>Q<br>fu||0<br>Ctl<br>Ol<br>fu||mIh<br>r<br>al'<br>fu|m<br>Cf<br>tu|Cl||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||||||||Iu||||||||Iu||
||||||V<br>u4l|u/||Ch<br>m<br>cl'|||IO<br>Ch<br>r<br>cr<br>CO<br>0|th<br>Cf<br>ru<br>r<br>IO<br> fu||Ih<br>00O<br>Ct||Ch<br>IO<br>tu||||OI<br>IO<br>IV<br>O<br>00||
||||||CC'|||||||||||m||||||
||||||0<br>ta<br>V|W||IO<br>O <br>m<br>Ch<br>00 <br>/I|Ol<br> Q<br>Ca<br> m|||||||||rn<br>I/I<br>I<br>tuar|m<br>I/I<br>ru<br>Cl'<br>ru|fum||
||||||Ql<br>C|||m|ut|||||||||||CO||
|||||M <br>fuO <br>fu|0<br> 0<br> l-|ul||Ol <br>0<br>IO|m<br> O<br>OI<br> O|||||||mthfu<br>IO||||CO<br>/4<br>CO||
|||||||||M|h|||||||IXI||||CO||
|||||||ut||CO||||||||||||CO||
||||||IU<br>IJ|||m<br>CI||||||||mQ||||m<br>Cl||
|||||||||Ch<br>Ifl||||||||Ch<br>m||||m||
||||||N|||||||||||||||||
||||||Ql|||||||||||||||||
||||||0|W|||m|||||||||||m||
||||||Ql<br>V|||r<br>CC|O|||||||tu||||CI||
|||||||||CC|Ol|||||||M||||||
||||||Ql|||M|I/I|||||||||||||
||||||||||||||||||||||5/|
||||N4I||||||||||||||0.<br>0<br>Q|||N<br>Cl|IUIJ0.<br>0Z|
||||||||||||||||||a0|||||
|0e<br>44O<br>ru<br>v C<br>la<br>fh<br>IQ<br>0. —5<br>0 m<br>0 0<br>00 —40<br>IL 0<br>IU<br>4ID 00<br>laDve<br>0<br>e<br>4I<br>O<br>V 0<br>Xzw|||ClDIa<br>IC<br>V<br>E0<br>Cl<br>E0VC||||tO <br>CJ<br>I/I<br>Z<br>Z|0 <br>U <br>ll<br>0Z<br>C <br>tU<br>ta <br>D<br>C<br>0<br> ~<br>0 <br>UJ|ClU<br>CL<br> 0<br> Z<br>IU<br>fa<br> D<br>C<br> 0<br>Qt<br> 0<br>tu|W<br>I/I<br>Z<br>Z|0 <br>U <br>'0. <br>I<br>0Z<br>C<br>Cl<br>ICD<br>C<br>0<br>&<br>Ql <br>ut|01<br>LI0.<br> 0<br> Z<br> C<br>Ct<br>fa<br>C<br>Ql<br>C<br>0<br> 0<br>CJ|QtIt<br>Qt 0<br>v Z<br>'0. C<br>tU<br>0Z<br>ta<br>Ql<br>C<br>0<br>fa<br>0 D<br>C<br>C 0<br>nl<br>0<br>aC 2<br>C<br>ct 0<br>CWtu<br>0|||Qt<br>0<br>t/<br>faO<br>IU<br>CI0.<br>0<br>fa<br>0|C<br>0<br>E <br>0<br>CJ <br>Cl<br>V<br>C<br>V<br>00<br>5 <br>0<br>0 <br>0|IU<br> .U0.<br> Z<br>C<br>4I<br>Yll<br>C<br> &<br>Ql<br> Iu|4l<br>0!<br>CJ<br>C<br>E<br>E0<br>El<br>0<br>Cl0<br>I/I|'8<br>ClDla<br>Ia<br>IJ<br>E0<br>4l<br>E0IJ0<br>IC0|'0<br>Cl<br>4IIJ<br>4I<br>tll<br>Cl<br>E0IJC<br>UJ<br>I/IZ|





|||||ru <br>ruO <br>tu|e<br> 0|ui||m<br>ID<br>tdl<br>ch<br>ID|Ch<br>IVI<br>m<br> d'||r<br>id|ftl<br>r<br>ul<br>0|dr'<br>oi<br>ID<br>Ctl||ru<br>ruO <br>ru|td<br> 0|w||foal<br>00<br>r <br>O|id<br>ul<br>I/I<br> o|CQ<br>m<br>m|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||||||||||||ru|||||||||
||||||'0<br>4I<br>IJ|tdl||CO<br>CO|4'||||CI<br>dr|||'0<br>QlJ|W|||||
||||||4l||||||||rd|||Cl||||||
||||||CC|||||||||||CC||||||
||||||'0<br>Cl<br>IJ<br>u<br>Cl|W||r<br>Ch<br>IQ<br>ul|r<br>ID<br>ID<br>m||O<br>CO|00<br>ID||||o<br>Cl<br>IU|ul||m<br>r00 <br>O|IV<br> ul<br>O<br> m|dr<br>CQ<br>m|
|||||m <br>IVO <br>(4|e <br> 0|w|||||\O|d<br>dl'<br>I|CC<br>ID||IVI <br>O <br>iu|0<br> 0|W|||||
||||||||||||ru|Ol<br>ID|rm|||||||||
||||||0 <br>Cl|w||tu<br>CO|'||iu<br>dr||tu|||0<br>Cl|W|||||
||||||U|||ID|||I/I<br>rh||Ol|||tJ||||||
||||||||||||||fu|||A||||||
||||||4I|||||||||||Cl||||||
||||||4l<br>IJ<br>u4I<br>0|ui||Ul<br>CO<br>O|ul<br>I/I<br>CQ<br>dl'<br>ttl||OI <br>Io<br>Ih<br>ru<br>m|d<br>'cr<br>r<br>Ol<br>ID|m<br>00<br>m<br>/Im'|||10 <br>CJ<br>IJ<br>Cl|W||ID<br>ru<br>dl'<br>O<br>IA|ID<br>ID|O<br>r|
||||ttl|||||||||||||||||||
||||CI|||||||||||||||||||
||||'8|||||||||||||||||||
||||OI|||||||||||||||||||
|0e m<br>E lu<br>e O<br>ldC<br>ld<br>th<br>td<br>O'V 2<br>C +<br>0 eC4e '0<br>C 0<br>4l<br>dl<br>Ow<br>e<br>0» e<br>4I<br>0XZ4<br>0 0|||000<br>10<br>IC<br>Cl<br>0<br>E0<br>Cl<br>E0IJ0||||0 <br>IJ<br>000 <br>dl<br>C|4J <br>U <br>Q<br>0<br> c<br>Cl<br>fll <br> 0<br>uJ<br>dl|QlIJ0.<br> 0<br> Z<br>dl<br>rd<br>C<br> 0<br>C<br>U<br> 0|U <br>C <br>tU<br>0<br>C<br>0 <br>U<br>0<br>I/I|0.<br> 0Z<br>C<br>e<br>td<br>C<br> 0<br>td<br>UJ|Cl\J<br>td<br>JQ<br>C<br>N<br>C<br>0<br> U||0V0||||IU<br>C<br>U<br>Cl<br>6.<br>E e 8<br>U Z<br>IU<br>0,<br>0 0<br>td<br>C Cl<br>Cl<br>0<br>C<br>tl! 0<br>E0 0<br>e + c<br>E—<br>0<br>td 0<br>U<br>UJ U<br>C||||





||||||0|0|Ul|0<br>0<br>d<br>Vl|ca<br>Ol<br>aa<br>Ul1|Do<br>t<br>Ul|co<br>IIl<br>Ol|o <br>Ch|vt<br>0 <br>UI<br>m|0<br>r<br> d<br>Do<br>Itl|Vl<br>ID|Da<br>m<br> 0<br>Vl|CO<br>lt<br>r|ca|0<br>th<br>Vl<br>rn|m <br>N <br>O<br>Oo<br>0|d<br> 0<br>CO<br>Ol|co<br>I<br>Ul<br>'d|co<br>co<br>Ol<br>Ch|m<br>CO<br>N<br>(1<br>M|r<br>N <br>r<br>IO<br>M|m<br> 0<br>to<br>th|m<br>Ch<br>IO|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||||(U|||||||||||||||||||O|||||||
||||||m0|0||Ul<br>MO|N<br>ca|Ol<br>Ca|ar<br>Vl<br>1<br>(U|I<br>(U<br>m|00<br>(C<br>Ol<br>m|0<br>0 0 <br>d <br>r'm<br>0 d <br>(1||m<br> N<br> 0<br>oi<br> d|I<br>m<br> 0|Ol<br>IO|Ol<br>ct<br>N<br>Ct|Ch<br>Ol<br>Ul<br>0|0<br>I<br>CO|Vl<br>m<br>IO<br>ID|Vl<br>r<br>N|m<br>r<br>Vl<br>ta <br>M|LD<br>N<br> 0<br>N|rh<br>I<br>th<br> 0lt|rCI<br>CI<br>m|||||Cl<br>m||
|||||||||||||||||||||||||||||||||CO||
||||||0<br>0<br>«L||W|Ch<br>CI<br>\0lt<br>Ul<br>N||I<br>Ol<br>CO|ID<br>Ul||||||m<br>CI<br>m|||0<br>r<br>vi<br>m<br>m|0<br>r<br>co<br>m|r<br>«h<br>r<br>ca<br>I|LD<br>ro|m<br>I<br>oo||CD<br>CO<br>m<br>Ol|o|0 <br>N<br>m<br>CO|m<br>ch<br> 0<br>Io|||||
||||||IL|||||||||||||||||||||||||||||
||||||Vl|||||||||||||||||||||||||||||
||||||Cl<br>0C<br>cl||W|||||||||M<br>O<br>thI|'|Ch<br>Ul|||||||||IID<br>Ol|||Ul<br>Ol0<br>DoN|\O<br>UI|||
||||||00|||||||||||||||||||||||||||||
|||||Dl|E<br>E0V|Cl<br>V|UI|rl<br>M|r<br>CI||||||||||||||||||Ch<br>Ch <br>Ch<br>O|Co<br> O0<br>(<br>Vl||m|Ul<br>r|O<br>Ci<br>0<br>t|m<br>N|
|||||V4||||||||||||||||||||||||||||||
|||||cl||||||||||||||||||||||||||||||
|||||JJ||||||||||||||||||||||||||||||
|||||4<br>V|D<br>0<br>Cl|to<br>V<br>D||N|0<br>m(1||||||||||Ol<br>m<br>Ct|co<br>IO<br>(1<br>IO|||vt<br>m<br>Itl<br>\D|||0<br>Co<br>te<br>IV|Vl <br>I<br>IO|(<br>Ol<br> th <br>CO<br>Ol|m <br>N<br> 0<br>N<br>IO|0 <br>(1<br>Ol|d<br>ra|UI<br>r<br>Ch<br>CO|UI<br>ID<br>CO<br>CaN<br>O|
||||||4|||||||||||||||||||||||||||||
||||||CL0|||||||||||||||||||||||||||||
||||||aa<br>Tl<br>0|0|W|UI<br>CO<br>Vl0<br>CO<br>(1||||(1|Ol<br>m|Vl <br>0 <br>r<br>O|0<br> 0<br>m||||0<br>Do<br>m|m<br>Vl<br>Ol<br>Ch||0<br>r|||0tt|rIO0<br>co|Ch lo<br>moto<br>oem <br>Ul I<br>Ca<br>DO<br>IO<br>CO<br>Do<br>CO<br>m|||mr<br> tor<br>co (1||m<br>m<br>Vl<br>Ol|Vl<br>mm<br>m|
||||||0V|||||||||||||||||||||||||||||
||||la|||||||||||||||||||||||||||||||
||||or|||||||||||||||||||||||||||||||
||||C0|||||||||||||||||||||||||||||||
||||IJ|||||||||||||||||||||||||||||||
||C0|m|al|||||||||||||||||||||||||||||||
|E<br>CU<br>0 0<br>v Id<br>lo<br>Cn<br>OI<br>a —j<br>C0 m<br>0 —ZI<br>IL 0<br>g DID<br>0<br>IO<br>III0<br>ol<br>0<br>O<br>XZW|||DIC<br>4la.<br>X<br>4I<br>000<br>loC|||||~I0Z<br>0<br>V<br>0|Clo0<br>00V<br>nt<br>V<br>la<br>CI|Dl <br>00a <br>X<br>Cl<br>0|0V<br>Cl<br> 0<br> .—<br>C<br>E<br>Dlla<br>C<br>D|.e <br>U<br>ra<br>0 <br>0|0V<br>Cct<br>0<br>0<br> ll|(D <br>0|Cl<br>Oa4<br>D<br>E<br> 0|Ct<br>0<br>C<br>0<br>V <br>V4<br>llC4<br>0|4<br>C0<br>~I<br> 0<br>Q <br>Cl<br>ao|0|tlDc<br>0<br>DV|0<br>E<br>CI<br>CL|I0D.<br>00<br>0<br>11<br>C<br>C0<br>4<br>J<br>CI<br>a<br>ID|Dl<br>U<br>C<br>I|a <br>E <br>0 <br>Cl<br>U<br>0 <br>4C<br>Cl<br>C0|00<br>DU<br> o<br> a<br>C <br> e<br>C<br> 0<br>Q<br>CV <br> 0|d<br>CI<br>4I<br> 0<br>al|ClJl<br>Dl<br>E<br>C0V||Z<br>UJ <br>0 <br>0 <br>a <br>Ul|Z<br> V <br> 0<br> 0 <br> a.<br>Vl|z<br> 0V<br>Dl<br>UC0C<br> e|Z<br>0<br>U<br>e<br>UC<br>C<br>4<br>00|Pv<br>NON<br>4I<br>DD<br>0<br>0<br>I|CI<br>Cl<br>14C<br>~IO.<br>X<br>Cl<br>Ia0|





||||||IU <br>O|«w <br> 0|«w <br> 0|o<br>Pl<br>O<br>d<br>UI|co<br>Ch<br>co<br>IO<br>m|~0<br>d <br>ln|lo<br>th<br> 0<br>I|r<br>O<br>M<br>Ol|m <br>UtO<br>Ul|0<br>00<br>Ch|Ut<br>h<br>0!|Co<br>N<br>m<br> 0<br>Irl|Co<br>f<br>r<br>N<br> d|Co<br>N|lrl<br>m|Ul<br>O<br>Co <br>O|cr<br>O<br>00<br> 0<br>N|co<br>lO<br>nr<br>ln|ao<br>CO<br>Ol<br>cn<br>IU|m<br>~0<br>I<br>m|N|m<br>O<br>tfUl|m|||||m<br>m|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||||0<br>0|||mlo<br>CO<br>IO<br>nr||||||||||||\0«I <br>0<br>O|cr<br> O<br>Co<br>Ch|OU!<br>O<br>«I|N<br> O<br>O|«I<br>i<br>m|||f <br>Ol|OI1|Ol<br>m||||
||||||O.||||||||||||||||||||||||||||
||||||Ul||||||||||||||||||||||||||||
||||||Cl<br>V<br>«C|U|UJ|||||||||Co<br>0<br>I|'|CO<br>N<br>i|||||||||IO<br>m<br>I<br>O|||0 <br>m<br>co<br>r|O<br>O<br>r||
||||||Cl||||||||||||||||||||||||||||
||||||0||||||||||||||||||||||||||||
||||||IO||||||||||||||||||||||||||||
|||||||U|w|m|N<br>nr||||||||||||||||||o <br>nr<br>0|r<br>Ln||||m|
|||||||||I|nr«I||||||||||||||||||Oi|I<br>m||||m<br>\0|
|||||||||Co|||||||||||||||||||O|Co||||r|
|||||Cl|0|||||||||||||||||||||||||||rn|
|||||U|||||||||||||||||||||||||||||
|||||nl|||||||||||||||||||||||||||||
|||||ClDta|||||||||||||||||||||||||||||
|||||ta|ta<br>CI<br>C<br>4I|0||m<br>r<br>IO|ra||||||||||O<br>N|IU<br>d<br>Co<br> 4<br>IO<br>Ul|||nl<br>0<br>Ul<br>Oi<br>0|||m<br>rh<br>m<br>Ol<br>Co|UI<br>nrat<br>th|O<br>O|tn|Co <br>Co<br>m|O<br> 0||
||||||ta||||||||||||||||||||||||||||
||||||CL<br>C||||||||||||||||||||||||||||
||||||00<br>C <br>0|0||||||r<br>rn<br>0th<br>0 <br>Ol<br>Ul<br>ra||O<br>r<br> d<br>Co<br>ch|m||||O|O<br>Ul<br>IO<br>O|||||r<br>N<br>r<br>lo<br>m|ao<br>N<br>Cli|ca<br>r<br>d<br>IO|r<br>Co<br>r<br>UI|||||
||||||0||||||||m||||||m||||||||co|r|||||
||||||0IJ||||||||||||||||||||||||||||
||||lo||||||||||||||||||||||||||||||
||||Cl||||||||||||||||||||||||||||||
||||0||||||||||||||||||||||||||||||
||||a||||||||||||||||||||||||||||||
||0||||||||||||||||||||||||||||||||
||4l|M|CI||||||||||||||||||||||||||||||
||E|04|||||||||||||||||||||||||||||||
|4I<br>lo<br>lrl<br>CO<br>04<br>IJ<br>nl<br>o. —j<br>0<br>m<br>IL<br>ClD<br>C<br>4I<br>D«O<br>0<br>0!<br>4I<br>Cl<br>2ZW0|||C<br>Cla«<br>Cl<br>0<br>lo|||||Cl<br>0Z<br>o <br>U<br>Ut|D<br>E<br>C0IJ<br> «<br>U<br>nn|0<br>C<br>«<br>Cl<br>0|0<br>~I<br>0<br>0<br>E<br>0<br>C0|Cl<br>I<br>C|0<br>000<br>tl0<br>0|V<br>Cl<br> 0|CI<br>E<br>CI<br>0<br>00<br>0<br>C<br>nl|V00L<br>I<br>Cl<br>CI<br>«<br>C<br>0<br>U|0C0<br>~I0<br>C<br>0<br>C<br>lotn<br>Cl|0<br>V|00<br>C <br>CI<br>0<br>U|0<br>E<br>tU<br>tL|0<br>4!<br>0<br>01!<br>C<br>nl<br>0 <br>U<br>ta<br>a0<br>CI|0<br>0<br>nl|C0<br>nlV<br>0 D<br>E a<br>0<br>C<br>«nl<br>tU<br>0<br>0<br>0<br>c a <br>0c<br>D<br>2<br>U||Cl<br>nl<br> 0<br>0V<br>0|«<br>a<br>E<br>C0<br>U||Z<br>I<br>0 <br>V<br>0 <br>a <br>a <br>Ul|Z<br>U<br> 0<br> 0<br> a<br> a<br>Ul|Z<br>0 <br>V<br>Cl<br>V<br>C<br>0<br>C<br>al<br>0 <br>to|Z<br>U<br> 0<br>V<br>4I<br>U<br>0<br>tn<br>L<br>tn<br> 0|IU<br>4<br>CI<br>ra<br>4I<br>'00<br>4Io.<br>IC<br>Cl<br>la0<br>I|





## 

|This is sta|ted after|char|ging||||
|---|---|---|---|---|---|---|
||||||2023|2022|
||||||E|E|
|Depreciation|||||387,012|298,014|
|Operating|lease rentals:||||||
|Property<br>- EMH|||||199,539|196,550|
|Property<br>- CMH|||||147,335|109,647|
|Auditor's|remuneration||(excluding|VAT):|||
|Audit|- EMH||||24,650|22,250|
|Audit|- CMH||||20,600|18,750|
|Other|services|- EMH|||1,300|1,250|
|Other|services|—CMH|||1,300|1,250|



|Staff costs were as|Staff costs were as|follows:||||||
|---|---|---|---|---|---|---|---|
|Current year||||||2023||
||||||EMH|CMH|Total|
||||||E|E|E|
|Staff under|service|level agreement|with|NHS|732,360|3,597,801|4,330,161|
|Wages and|salaries||||4,898,863|1,308,906|6,207,769|
|Employer's|national|insurance|||466,615|368,934|835,549|
|Pension costs|||||545,763|419,656|965,419|
|Temporary|and agency staff||||907,991|400,014|1,308,005|
|Other staff|costs||||333,373|223,336|556,709|
||||||7,884,965|6,318,647|14,203,612|



|Prior year||||||2022||
|---|---|---|---|---|---|---|---|
||||||EMH|CMH|Tata<br>I|
||||||E|E|E|
|Staff under|service|level agreement|with|NHS|731,585|3,079,246|3,810,831|
|Wages and|salaries||||4,351,522|1,333,403|5,684,925|
|Employer's|national|insurance|||396,510|291,71&|688,228|
|Pension costs|||||495,878|388,283|884,161|
|Temporary|and agency staff||||745,748|268,681|1,014,429|
|Other staff|costs||||224,077|234,379|458,456|
||||||6,945,319|5,595.710|12,541,030|





## 

|The following<br>number<br>of employees<br>received employee<br>insurance)<br>during the year between:|benefits (excluding<br>employer<br>pension costs and|national|
|---|---|---|
||2023|2022|
||No.|No.|
|E60,000 - E69,999|1|1|
|E70,000 - E79,999|1|1|
|E80,000 —E89,999|2|1|
|E90,000 - E99,999|1|1|
|E100,000 - E109,999||1|
|E110,000 - E119,999|||



## 

|9.<br>St|aff numbers|||||
|---|---|---|---|---|---|
|||2023|2023|2022|2022|
|||Employed|Recharged|Employed|Recharged|
|||by Charity|to Charity|by Charity|to Charity|
|||No.|No.|No.|No.|
|Fundraising|- EMH|11||10||
|Fundraising|-CMH|5||32||
|In patient|unit / Patient services - EMH|68||52||
|In patient|unit / Patient serwces - CMH|79||137||
|Community||107||56||
|Day unit /|JCC|18||10||
|Retail||61||4(||
|Support||80||43||
|||429||381||



## 

## 

## 



## 

|12.<br>Tangible fixe|d assets||||||
|---|---|---|---|---|---|---|
|||||Fixtures,|||
|||Land and|Leasehold|fittings and|Motor||
|Group||buildings|improvements|equipment|vehicles|Total|
|||E|E|E|E|E|
|Cost|||||||
|At the start of the year||11,112,676|250,674|2,454,453|261,197|14,079,000|
|Additions<br>in year||57,433|35,858|265,394|2,500|361,185|
|Disposals<br>in year|||||||
|Transfers||(136,940)|136,940||||
|At the end ofthe year||11,033,169|423,472|2,719,847|263,697|14,440,185|
|Depreciation|||||||
|At the start ofthe year||153,372|43,126|1,961,745|201,884|2,360,127|
|Charge for the year||13,042|75,746|271,939|26,285|387,012|
|Depreciation<br>ehminated|on disposal||||||
|Transfers||(122,951)|122,951||||
|At the end ofthe year||43,463|241,823|2,233,684|228,169|2,747,139|
|Net book value|||||||
|At the end ofthe year||10,989,706|181,649|486,163|35,528|11,693,046|
|At the start ofthe year||10,959,304|207,548|492,708|59,313|11,718,873|
|||Freehold||Fixtures,|||
|||land and|Leasehold|fittings and|Motor||
|Earl Mountbatten<br>Hospice||buildings|improvements|equipment|vehicles|Total|
|||E|E|E|E|E|
|Cost|||||||
|At the start ofthe year||11,062,094||2,031,583|261,197|13,354,874|
|Additions<br>in year||55,860||27,555||83,415|
|Disposals<br>in year|||||||
|Transfers||(136,940)|136,940||||
|At the end ofthe year||10,981,014|136,940|2,059,138|261,197|13,438,289|
|Depreciation|||||||
|At the start ofthe year||122,951||1,747,339|201,884|2,072,174|
|Charge for the year|||7,760|115,117|25,790|148,667|
|Depreciation<br>eliminated|on disposal||||||
|Transfers||(122,951)|122,951||||
|At the end ofthe year|||130,711|1,862,456|227,674|2,220,841|
|Net book value|||||||
|At the end ofthe year||10,981,014|6,229|196,682|33,523|11,217,448|
|At the start ofthe year||10,939,143||284,244|59,313|11,282,700|





## 

||||||Group||Earl Mountbatten|Hospice|
|---|---|---|---|---|---|---|---|---|
||||||2023|2022|2023|2022|
||||||E|E|E|E|
|Listed investments|||||||||
|Fair value||at the|start ofthe year||6,385,986|5,794,747|4,827,958|4,462,912|
|Additions||at cost|||1,257,071|1,689,251|955,107|1,319,277|
|Disposal proceeds|||||(7,190,428)|(1,383,104)|(5,463,195)|(1,078,776)|
|Net (loss)/gain<br>on change||||in fair value|(421,000)|285,092|(319,870)|124,545|
||||||31,629|6,385,986||4,827,958|
|Cash held||by investment||broker pending|||||
|reinvestment||||||1,424,854||1,082,889|
|Investment||in group undertaking|||||||
|Fair value||at the|end ofthe year||31,629|7,810,840|2|5,910,849|
||||||||2023|2022|
||||||||E|E|
|UK Bonds||||||||497,542|
|Overseas||Bonds|||||31,629|426,507|
|UK Equities||||||||1,662,869|
|North American|||Equities|||||1,560,358|
|European||Equities||||||407,543|
|Japanese||Equities||||||220,427|
|Asia Pacific Equities||||||||523,137|
|Emerging||Market|Equities|||||99,881|
|Global Investments||||||||298,476|
|Absolute|Return|||||||208,631|
|Property|Trusts|||||||212,522|
|Other||||||||268,093|
|Cash||||||||1,424,854|
||||||||31,629|7,810,840|





## 

||||||||Countess||
|---|---|---|---|---|---|---|---|---|
|||||||Countess|Mountbatten|Earl|
|||||||Mountbatten|Hospice|Mountbatten|
|||||||Hospice Charity|Promotions|Hospice Trading|
|Year ended|31March 2023|||||Limited|l.imited|Limited|
|||||||6|E|E|
|Income/<br>turnover||||||6,968,189|402,733|104,069|
|Cost of sales|||||||(131,389)|(8,461)|
|Net income/|gross profit|||||6,968,189|271,344|95,608|
|Net expenditure<br>/||administratwe||expenses||(9,182,898)|(18,202)|(36,158)|
|Distribution|from subsidiary|||||482,590|||
|Loss on investment||assets||||(101,130)|||
|Net income/(expenditure)/profit/(loss)|||||for the financial||||
|year||||||(1,833,249)|253,142|59,450|
|Funds/retamed<br>earnings<br>brought||||forward||3,339,377|477,536||
|Net income/(expenditure)/profit/(loss)|||||for the financial||||
|year||||||(1,833,249)|253,142|59,450|
|Distribution|under|Gift Aid to parent|||charity||(482,590)|(59,450)|
|Reserves/retained||earnings|carried forward|||1,506,128|248,088||
|The aggregate of the assets,|||kabilities||and funds was:||||
|Assets||||||2,927,144|288,307|27,333|
|Liabilities||||||(1,421,016)|(40,217)|(27,331)|
|Funds||||||1,506,128|248,090||





## 

||||||||Countess||
|---|---|---|---|---|---|---|---|---|
|||||||Countess|Mountbatten|Earl|
|||||||Mountbatten|Hospice|Mountbatten|
|||||||Hospice Charity|Promotions|Hospice Trading|
|Year ended 31March 2022||||||Limited|Limited|l.imited|
|||||||E|E|E|
|Income / turnover||||||9,335,716|373,587|78,305|
|Cost ofsales|||||||(118,092)|(6,699)|
|Net mcome/gross|profit|||||9,335,716|255,495|71,606|
|Net expenditure/administratwe|||expenses|||(8,028,476)|(26,047)|(35,893)|
|Distnbution<br>from|subsidiary|||||57,660|||
|Gain on investment|assets|||||160,547|||
|Net (expenditure)/profit<br>for||the|finanmal||year|1,525,447|229,448|35,713|
|Funds/retained<br>earnings<br>brought|||forward|||1,813,930|305,748|(2,195)|
|Net income/(expenditure)/profit/(loss)||||for the financial year||1,525,447|229,448|35,713|
|Distribution<br>under|Gift Aid to parent|||charity|||(57,660)|(33,518)|
|Reserves/retained|earnings|earned forward||||3,339,377|477,536||
|The aggregate ofthe assets,||liabilities||and|funds was:||||
|Assets||||||4,738,226|535,666|37,019|
|Liabilities||||||(1,398,849)|(58,128)|(37,017)|
|Funds||||||3,339,377|477,538||



## 

## 



## 

|||2023|2022|
|---|---|---|---|
|||E|E|
|Gross|income|8,784,402|10,471,563|
|Result|for the year|(1,814,204)|1,272,168|
|16.|Debtors|||



|||Group||Earl Mountbatten|Hospice|
|---|---|---|---|---|---|
|||2023|2022|2023|2022|
|||E|E|E|E|
|Amounts|due from group entities|||22,732|211,712|
|Trade debtors||243,165|81,012|203,812|24,034|
|Accrued|income and other debtors|168,864|3,418,215|130,330|1,452,771|
|VAT recoverable||99,956|148,381|59,140|97,057|
|Prepayments||177,778|172,084|126,808|136,486|
|||689,763|3,819,692|542,822|1,922,060|



|17.<br>|Creditors: amounts<br>falling due wi|thin one year||||
|---|---|---|---|---|---|
|||Group||Earl Mountbatten|Hospice|
|||2023|2022|2023|2022|
|||E|E|E|E|
|Trade creditors||447,381|556,061|246,376|258,256|
|Deferred|income|69,718|69,718|69,718|69,718|
|Other creditors and accruals||1,779,497|903,667|613,781|268,999|
|Amounts|due to group entities|||9,074||
|||2,296,596|1,529,446|938,949|596,973|



## 

|||||Group||Earl Mountbatten|Hospice|
|---|---|---|---|---|---|---|---|
|||||2023|2022|2023|2022|
|||||E|E|E|E|
|Balance|at the beginning<br>ofthe year|||69,718|623,041|69,718|318,041|
|Amount|released|to income|in the year||(553,323)||(248,323)|
|Amount|deferred|m the year||||||
|Balance|at the end ofthe year|||69,718|69,718|69,718|69,718|





## 

## 

## 

## 



## 

|20.a)<br>Analysis ofgroup net assets between|funds - 2023||||
|---|---|---|---|---|
||General|Designated|Restricted|Total|
||unrestricted|funds|funds|funds|
||E|E|E|E|
|Tangible fixed assets|372,201|9,020,915|2,299,930|11,693,046|
|Investments|31,629|||31,629|
|Net current assets|5,618,635|552,520|1,115,804|7,286,959|
|Net assets atthe end ofthe year|6,022,465|9,573,435|3,415,734|19,011,634|



|20.a)<br>Analysis ofgroup net assets between|funds<br>-2022||||
|---|---|---|---|---|
||General|Designated|Restricted|Total|
||unrestricted|funds|funds|funds|
||E|E|E|E|
|Tangible fixed assets|368,040|9,020,915|2,329,918|11,718,873|
|Investments|7,310,840|500,000||7,810,840|
|Net current assets|2,186,351|52,520|1,130,587|3,369,458|
|Net assets atthe end ofthe year|9,865,231|9,573,435|3,460,505|22,899,171|





## 

|21.a) Mov|e|ment<br>in funds|- 2023|||||||
|---|---|---|---|---|---|---|---|---|---|
||||At 1 Apnl|||Gain on|||At 31|
||||2022|Income|Expenditure|revaluations|Transfers||March 2023|
||||E|E|E|E||E|E|
|Restricted funds||||||||||
|Capital funds||||||||||
|John Cheverton<br>estate||fixed||||||||
|asset fund|||74,274||(29,988)||||44,286|
|Fixed Asset Fund|||2,255,644||||||2,255,644|
|Revenue funds||||||||||
|Community<br>equipment|||2,678||(2,678)|||||
|Clinical Co-ordination||Centre|192,057||(150,844)||||41,213|
|iBCF|||97,227|80,000|(143,223)||||34,004|
|Kelly donation|||505||||||505|
|Young adult services|||56,584||(33,875)||||22,709|
|DC clinical teaching post||||15,171|(15,171)|||||
|NHS CCG - CQUINs||||39,038|||||39,038|
|KissyPuppy<br>restricted||fund|341,513|113,591|(55,524)||||399,580|
|Advanced<br>communication|||4,651||(903)||||3,748|
|MND Clinic|||9,451||(2,524)||||6,927|
|Responsible<br>communities|||65,075||(65,075)|||||
|Mountbatten<br>young|adults||5,114||(2,645)||||2,469|
|Barclays donation|||75,276||(8,998)||||66,278|
|Ward Furniture|||4,616||(3,604)||||1,012|
|Oak Garden<br>Decking|||5,500||(5,500)|||||
|Butterfly &Chelsea Garden||||||||||
|Maintenance|||5,000||(5,000)|||||
|Bladder Scanners|||8,000||(917)||||7,083|
|Hoist Pods for IPU|||4,560||(880)||||3,680|
|Essential<br>Equipment|for patient|||||||||
|Care|||4,618|2,200|(2,555)||||4,263|
|Gen Don-Community||||12,681|(12,681)|||||
|Gen Don-Lymphoedema||||100|(100)|||||
|Donations for Staff||||703|(703)|||||
|JC Pool Vehicle Fund||||250,000|||||250,000|
|Daisy Rich Trust||||1,000|||||1,000|
|Hospital<br>Saturday<br>Fund||||2,000|||||2,000|
|Other restricted<br>funds|||8,676|1,011|(342)||||9,345|
|Total restricted<br>funds||EMH|3,221,019|517,495|(543,730)||||3,194,784|





|21|.a) M|o|veme|nt<br>in fund|s —2023 (cont.)|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
||||||||||||At 31|
||||||At 1 April|||Gain on|||March|
||||||2022|Income|Expenditure|revaluations|Transfers||2023|
||||||E|E|E|E||E|E|
|Restricted funds -|||CMH|||||||||
|NHSE|||||98,870||(27,070)||||71,800|
|Other|||||140,616|81,437|(72,903)||||149,150|
|Total restricted funds|||||3,460,505|598,932|(643,703)||||3,415,734|
|Unrestricted|funds||-EMH|||||||||
|Designated|funds:|||||||||||
|Fixed Asset|Fund||||9,073,435||||||9,073,435|
|Total designated||funds||- EMH|9,073,435||||||9,073,435|
|Designated|funds||- CMH||500,000||||||500,000|
|Total designated||funds|||9,573,435||||||9,573,435|
|General funds —EMH group|||||5,957,898|7,275,552|(9,749,624)|(319,870)|||3,163,956|
|General funds —CMH group|||||3,907,333|7,289,486|(8,237,180)|(101,130)|||2,858,509|
|Total unrestricted|||funds||19,438,666|14,565,038|(17,986,804)|(421,000)|||15,595,900|
|Total funds|- EMH||||18,252,351|7,793,047|(10,293,354)|(319,870)|||15,432,174|
|Total funds|- CMH||||4,646,820|7,370,923|(8,337,153)|(101,130)|||3,579,460|
|Total funds|||||22,899,171|15,163,970|(18,630,507)|(421,000)|||19,011,634|





## 

|21.b)<br>Movemen|t|in funds|- 2022|||||||
|---|---|---|---|---|---|---|---|---|---|
|||||At 1April|||Gain on||At 31March|
|||||2021|Income|Expenditure|revaluation||2022|
|||||E|E|E||E|E|
|Restricted funds||||||||||
|Capital funds||||||||||
|John Cheverton<br>estate||fixed asset fund||111,576||(37,302)|||74,274|
|Fixed Asset Fund||||2,255,644|||||2,255,644|
|Revenuefunds||||||||||
|Community<br>equipment||||12,475||(9,797)|||2,678|
|Clinical Co-ordination||Centre||333,521||(141,464)|||192,057|
|iBCF||||159,566|73,333|(135,672)|||97,227|
|Kelly donation||||505|||||505|
|Young adult services||||68,967|20,000|(32,383)|||56,584|
|DC clinical teachmg post|||||13,246|(13,2461||||
|NHS CCG -CQUINs|||||41,139|(41,1391||||
|Hospital discharge co-ordinator|||grant|1||(1)||||
|KissyPuppy<br>restncted||fund||269,148|100,810|(28,445)|||341,513|
|Advanced<br>communication||||4,651|||||4,651|
|MND Clinic||||12,205||(2,754)|||9,451|
|Responsible<br>communities||||66,750||(1,675)|||65,075|
|Mountbatten<br>young|adults|||5,144||(30)|||5,114|
|Barclays donation||||92,156||(16,880)|||75,276|
|NHSE|||||1,439,619|(1,439,619)||||
|Ward Furniture|||||8,707|(4,091)|||4,616|
|Education<br>Fund|||||4,215|(4,215)||||
|Oak Garden<br>Decking|||||5,500||||5,500|
|Butterfly &Chelsea Garden||||||||||
|Maintenance|||||5,000||||5,000|
|Online Bereavement|support||||2,584|(2,584)||||
|Infection Control Salary Costs|||||14,366|(14,366)||||
|Bladder Scanners|||||9,000|(1,000)|||8,000|
|Hoist Pods for IPU|||||5,520|(960)|||4,560|
|Essential<br>Equipment|For patient||Care||4,954|(336)|||4,618|
|SPOC/Palliative<br>Care|Hub||||47,593|(47,593)||||
|Music Therapy|||||3,000|(3,000)||||
|Rodwell donation|||||250,000|(250,000)||||
|Other restricted<br>funds||||8,211|13,371|(12,906)|||8,676|
|Total restricted<br>funds||EMH||3,400,520|2,601,957|(2,241,458)|||3,221,019|





## 

|21.b) Move|ment<br>|in funds —2022|(cont.)|||||
|---|---|---|---|---|---|---|---|
||||||||At 31|
||||At 1April|||Gain on|March|
||||2021|Income|Expenditure|revaluation|2022|
||||6|E|6|E|6|
|Restricted funds -||CMH||||||
|NHSE||||2,267,249|(2,168,379)||98,870|
|Other|||131,934|120,398|(111,716)||140,616|
|Total restricted<br>funds|||3,460,505|4,449,604|(4,521,553)||3,460,505|
|Unrestricted|funds|-EMH||||||
|Designated|funds:|||||||
|Fixed Asset|Fund||9,073,435||||9,073,435|
|Total designated<br>funds - EMH|||9,073,435||||9,073,435|
|Designated|funds|- CMH|500,000||||500,000|
|Total designated<br>funds|||9,573,435||||9,573,435|
|General funds —EMH group|||5,393,484|7,534,944|(7,095,184)|124,654|5,957,898|
|General funds —CMH group|||1,487,746|7,321,656|(5,062,616)|160,547|3,907,333|
|Total unrestricted||funds|16,454,665|14,856,600|(12,157,800)|285,201|19,438,666|
|Total funds|- EMH||17,867,439|9,596,900|(9,336,642)|124,654|18,252,351|
|Total funds|- CMH||2,119,680|9,709,304|(7,342,711)|160,547|4,646,820|
|Total funds|||19,987,119|19,306,204|(16,679,353)|285,201|22,899,171|





## 

## 

## 



## 

## 

## 

## 



## 

||||||||2023|2022|
|---|---|---|---|---|---|---|---|---|
||||||||E|E|
|Net (expenditure)/income<br>for the reporting|||||period||(3,887,537)|2,912,052|
|(as per the statement||offinancial activities)|||||||
|Depreciation<br>charges|||||||387,012|311,608|
|Profit on disposals|offixed assets|||||||(13,594)|
|(Gains)/losses<br>on investments|||||||421,000|(285,092)|
|Dividends,<br>interest|and rent||from investments||||(197,097)|(138,425)|
|(Increase)/decrease|in stocks||||||(7,369)|1,205|
|Decrease/(increase)||in debtors|||||3,129,929|(2,559,546)|
|Increase/(Decrease)||in creditors|||||767,150|(579,672)|
|Net cash (used in)/provided|||by operating|activities|||613,088|(351,464)|
|Analysis of cash and||«ash equivalents|||||||
||||||||2023|2022|
||||||||E|E|
|Cash<br>in hand|||||||8,884,194|1,076,983|
|Analysis ofchanges||in net debt|||||||
|||||||1 April|Cash flows|31March|
|||||||2022||2023|
|||||||E||E|
|Cash in hand||||||1,076,983|7,807,211|8,884,194|



## 

||||Group||Earl Mountbatten|Hospice|
|---|---|---|---|---|---|---|
|||2023||2022|2023|2022|
|||E||E|E|E|
|Less|than one year|347,398||306,275|156,898|160,441|
|One|to five years|1,276,558||805,333|593,725|382,667|
|Over|five years|784,117||11,250|355,200||
|||2,048,073||1,122,858|1,105,823|543,108|



## 

